Indostar Capital (INDOSTAR)

FairStock Score: 2/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of roughly 0.99 means investors are paying about book value, avoiding a large premium for asset value.
• Promoter holding of 70.39% is strong alignment and reflects insider confidence.
• Reported ROE of 17.78% suggests decent capital productivity if earnings normalise and the loan book performs.
• Current price of ₹196.50 is closer to the 52-week low of ₹179.03 than the high of ₹288.05, reducing euphoria risk.

Concerns

• Piotroski F-Score of 3/9 and FairStock Score of 0/100 indicate weak financial health.
• Profit growth is down 27.57%, and the latest quarter net profit is only ₹8 crore on ₹346 crore sales, showing very thin profitability.
• ROCE of 6.79% is low relative to debt/equity of 1.43, raising questions about whether leverage is earning its cost.
• No dividend means returns depend entirely on capital appreciation and a successful recovery.

AI Analysis

Indostar Capital looks like a classic Graham cautionary tale. At ₹196.50, the market is valuing the company at almost exactly its book value of ₹198.10. That sounds like a margin of safety, but in an NBFC, book value is only as good as the loan book. The picture underneath is weak. Sales have declined 7.19%, profit is down 27.57%, and the latest quarter delivered just ₹8 crore net profit on ₹346 crore of sales—a razor-thin margin. The reported ROE of 17.78% is hard to square with that; I trust the latest profit far more than a backward-looking ratio. The Piotroski F-Score of 3 out of 9 is a clear red flag: financial health is deteriorating. With debt/equity of 1.43, the company is not overleveraged for an NBFC, but leverage becomes uncomfortable when earnings shrink. No dividend means I am not paid to wait. Promoter holding of 70.39% is good alignment, and a price near the 52-week low of ₹179 adds some downside comfort, but interest alignment does not equal a durable moat. ROCE of only 6.79% suggests the underlying capital is not generating spectacular returns. Is this a value trap? Possibly. I do not need to buy every cheap stock. I need evidence that book value is intact, that loan recoveries are strong, and that quarterly earnings are stabilising. If those come, Indostar could be a turnaround. Until then, it is an asset-supported situation with serious earning-power problems. I would rather watch and wait than rely on hope.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer